U.S. Gamma Knife Market Size & Outlook, 2023-2030
U.S. gamma knife market, 2018-2030 (US$M)
Related Markets
U.S. gamma knife market highlights
- The U.S. gamma knife market generated a revenue of USD 129.6 million in 2023 and is expected to reach USD 189.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, malignant tumors was the largest revenue generating indications in 2023.
- Functional Disorders is the most lucrative indications segment registering the fastest growth during the forecast period.
Gamma knife market data book summary
| Market revenue in 2023 | USD 129.6 million |
| Market revenue in 2030 | USD 189.5 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Malignant tumors |
| Fastest growing segment | Functional Disorders |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases |
| Key market players worldwide | Elekta AB ADR, Varian, Akesis Pharmaceuticals, Huiheng Industry |
Other key industry trends
- In terms of revenue, U.S. accounted for 29.1% of the global gamma knife market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. gamma knife market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 189.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gamma Knife Market Scope
Gamma Knife Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. gamma knife market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gamma knife market will help companies and investors design strategic landscapes.
Malignant tumors was the largest segment with a revenue share of 46.3% in 2023. Horizon Databook has segmented the U.S. gamma knife market based on malignant tumors, benign tumors, vascular disorders, functional disorders, ocular diseases covering the revenue growth of each sub-segment from 2018 to 2030.
High prevalence of brain tumors, rise in healthcare expenditure, increase in access to gamma knife therapies, and growing adoption of technologically advanced radiotherapy systems are some of the major factors expected to drive the U.S. market. The country spends nearly 16.9% of its GDP on healthcare, more than any other OECD country.
According to OECD 2019 data, its spending is expected to increase up to 20% in 2030, improving the development of advanced radiological technology. In addition, the U.S. records nearly 178 cancer deaths per 100,000 populations and approximately 81,246 deaths were reported due to malignant brain cancer and other brain tumors from 2013 to 2017.
This calls for the adoption of noninvasive and highly precision stereotactic radiosurgery, such as gamma knives. Emergence of newer market players, such as Akesis, has also boosted market growth. The company received FDA marketing approval for two of its gamma knife systems, Galaxy RTi and Galaxy RTx, in March 2021.
Reasons to subscribe to U.S. gamma knife market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. gamma knife market databook
-
Our clientele includes a mix of gamma knife market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. gamma knife market , including forecasts for subscribers. This country databook contains high-level insights into U.S. gamma knife market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. gamma knife market size, by indications, 2018-2030 (US$M)
U.S. Gamma Knife Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
